← Back to catalogue

LiquiBand Exceed

FDA 510(k)FDA UDI

Class II (US FDA 510(k))

510(k) K151182

by Advanced Medical Solutions (Plymouth), Ltd.

Identity

Trade Name
LiquiBand Exceed FDA UDI
Generic Name
Skin-approximation adhesive FDA UDI
Model / Reference
LBE001 FDA UDI

Identifiers

Primary DI / UDI-DI
05036912001687 FDA UDI
510(k) Number
K151182 FDA 510(k)FDA UDI
FDA Product Code
MPN FDA 510(k)FDA UDI
GMDN Term
Skin-approximation adhesive FDA UDI

Classification

Device Class
Class II FDA 510(k)FDA UDI
Legislation / Framework
21 CFR Part 878.4010 FDA 510(k)
Regulation Number
878.4010 FDA 510(k)FDA UDI
Advisory Committee
General, Plastic Surgery FDA 510(k)
FDA Decision
SESE Substantially Equivalent FDA 510(k)
Commercial Distribution
In Commercial Distribution FDA UDI

Clinical & Handling

Sterile

Yes

FDA UDI

Single Use

Yes

FDA UDI

Implantable

No

FDA UDI

Contains Latex

No

FDA UDI

Prescription Use

Yes

FDA UDI

Over-the-Counter

No

FDA UDI

Convenience Kit

No

FDA UDI

Combination Product

No

FDA UDI

HCT/P

No

FDA UDI

Premarket Exempt

No

FDA UDI

Lot / Batch Number

Yes

FDA UDI

Serial Number

No

FDA UDI

Expiration Date

Yes

FDA UDI

Manufacturing Date

No

FDA UDI

LiquiBand Exceed is a tissue adhesive intended for the topical approximation of skin. It functions as a 2-octyl-cyanoacrylate adhesive device designed to provide wound closure.

This device is regulated under FDA 510(k) clearance K151182. It is intended for use in general and plastic surgery settings.

Frequently asked questions

What is the primary function of LiquiBand Exceed?

LiquiBand Exceed is a tissue adhesive formulated for the topical approximation of skin. It is designed to provide effective wound closure in clinical settings.

What type of chemical composition does this adhesive use?

This device utilizes 2-octyl-cyanoacrylate. This specific chemical formulation is used to create a strong, flexible bond suitable for closing skin wounds.

In which clinical environments is this device intended for use?

LiquiBand Exceed is intended for use within general and plastic surgery settings, where topical skin approximation is required for wound management.

Is this device subject to regulatory oversight?

Yes, LiquiBand Exceed is regulated under FDA 510(k) clearance K151182, which confirms its status as a device cleared for use in the United States.

This description and any FAQs above were generated automatically from registry data and have not been verified by the manufacturer or by deviCERTS. Always check the official registry entry and the manufacturer's instructions for use before relying on them. Sources consulted: LiquiBand® Exceed™ - Controlled Wound Closure, Traditional Topical Skin Adhesives - Advanced Medical Solutions, LiquiBand - Surgical Wound Closure - Choose your region, PDF LiquiBand Exceed Topical Skin Adhesive Summary of Effectiveness Da

Authorization Coverage (1 country)

Regulatory Authorizations

United States Active

FDA_510K

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Sources (2)

  • FDA 510(k) K151182 24 fields · synced Oct 6, 2026
  • FDA UDI b45447d4-bfe2-452d-b2c3-9b5bbbd2d88d 34 fields · synced May 26, 2026